Procaps Group S.A. (NASDAQ:PROC – Get Free Report) fell 37.3% on Tuesday . The stock traded as low as $0.95 and last traded at $0.97. 100,299 shares changed hands during trading, an increase of 690% from the average session volume of 12,704 shares. The stock had previously closed at $1.55.
Procaps Group Stock Performance
The business has a 50-day simple moving average of $1.91 and a 200-day simple moving average of $2.27. The company has a market cap of $109.44 million, a price-to-earnings ratio of 1.87 and a beta of 0.17.
Procaps Group Company Profile
Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.
See Also
- Five stocks we like better than Procaps Group
- Using the MarketBeat Stock Split Calculator
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- How to Invest in Small Cap Stocks
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- Retail Stocks Investing, Explained
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Procaps Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procaps Group and related companies with MarketBeat.com's FREE daily email newsletter.
